117 related articles for article (PubMed ID: 38684373)
1. Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF.
Zhao J; Li Z; Zhang H; Qin T; Zhao J; Pei Q
Chem Biol Drug Des; 2024 May; 103(5):e14533. PubMed ID: 38684373
[TBL] [Abstract][Full Text] [Related]
2. Recombinant hirudin suppresses the viability, adhesion, migration and invasion of Hep-2 human laryngeal cancer cells.
Lu Q; Lv M; Xu E; Shao F; Feng Y; Yang J; Shi L
Oncol Rep; 2015 Mar; 33(3):1358-64. PubMed ID: 25592110
[TBL] [Abstract][Full Text] [Related]
3. [Effect of MELK Inhibitor OTSSP167 on Diffuse Large B-Cell Lymphoma].
Zhou JY; Huang H; Zhuang Y; Zhong XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):739-745. PubMed ID: 37356934
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.
Haery L; Lugo-Picó JG; Henry RA; Andrews AJ; Gilmore TD
Mol Cancer; 2014 Feb; 13():29. PubMed ID: 24529102
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of pyrrolidine dithiocarbamate (PDTC) inhibits VEGF expression, tumor angiogenesis, and growth of breast cancer in female mice.
Gu JW; Young E; Busby B; Covington J; Johnson JW
Cancer Biol Ther; 2009 Mar; 8(6):514-21. PubMed ID: 19242105
[TBL] [Abstract][Full Text] [Related]
6. Cyclic-AMP signalling, MYC and hypoxia-inducible factor 1α intersect to regulate angiogenesis in B-cell lymphoma.
Ethiraj P; Sasi B; Holder KN; Lin AP; Qiu Z; Jaafar C; Elkhalili A; Desai P; Saksena A; Ritter JP; Aguiar RCT
Br J Haematol; 2022 Jul; 198(2):349-359. PubMed ID: 35411936
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
[TBL] [Abstract][Full Text] [Related]
8. [Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function].
Qiu C; Zhang QH; Wang GG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1415-1422. PubMed ID: 36208243
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.
Chanakira A; Westmark PR; Ong IM; Sheehan JP
Gynecol Oncol; 2017 Apr; 145(1):167-175. PubMed ID: 28148395
[TBL] [Abstract][Full Text] [Related]
10. Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma.
He Y; Li J; Ding N; Wang X; Deng L; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Song Y; Zhu J
J Exp Clin Cancer Res; 2019 Feb; 38(1):86. PubMed ID: 30777096
[TBL] [Abstract][Full Text] [Related]
11. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis.
Chen L; Zhan CZ; Wang T; You H; Yao R
Yonsei Med J; 2020 Jan; 61(1):20-29. PubMed ID: 31887796
[TBL] [Abstract][Full Text] [Related]
13. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.
Ganjoo KN; Moore AM; Orazi A; Sen JA; Johnson CS; An CS
J Cancer Res Clin Oncol; 2008 Mar; 134(3):381-7. PubMed ID: 17694324
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
[TBL] [Abstract][Full Text] [Related]
15. Silencing Aurora-kinase-A (AURKA) reinforced the sensitivity of diffuse large B-cell lymphoma cells to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) via suppressing β-Catenin and RAS-extracellular signal-regulated protein kinase (ERK1/2) pathway.
Wang S; Sun L
Bioengineered; 2021 Dec; 12(1):8296-8308. PubMed ID: 34565287
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells.
Kou J; Gao L; Ni L; Shao T; Ding J
Mol Biotechnol; 2024 May; 66(5):1062-1070. PubMed ID: 38184808
[TBL] [Abstract][Full Text] [Related]
17.
Guo Y; Du F; Tan YL; Luo J; Xiong D; Song WT
Biochem Cell Biol; 2021 Aug; 99(4):414-423. PubMed ID: 34319836
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma.
Tian M; Li Y; Zheng W; Liu QQ; Zhang XL; Liu JL; Zhang S; Sheng YX; Fan CB; Zhang WL
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2567-2576. PubMed ID: 33829443
[TBL] [Abstract][Full Text] [Related]
19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]